Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Previously undiagnosed myocardial infarction

Jason Tarkin, MBBS, MRCP
Gerald S Bloomfield, MD, MPH
Section Editor
Juan Carlos Kaski, DSc, MD, DM (Hons), FRCP, FESC, FACC, FAHA
Deputy Editor
Gordon M Saperia, MD, FACC


Incidental findings are common in medicine and often lead to diagnostic and management dilemmas. This topic discusses one such patient group: asymptomatic individuals who are found to have a previously undiagnosed myocardial infarction (MI).


According to the Third Universal Definition of MI, a silent MI is defined in an asymptomatic patient by new electrocardiogram Q wave criteria for MI or evidence of MI on cardiac imaging, which are not directly attributable to a coronary revascularization procedure [1]. (See "Criteria for the diagnosis of acute myocardial infarction", section on 'Prior MI'.)

The term "previously undiagnosed" MI is used synonymously to describe either a "silent" MI, when no symptoms are recalled by the patient, or an "unrecognized" MI in a patient who, despite experiencing atypical symptoms related to their MI, did not seek medical attention at that time as they did not recognize their symptoms to be harmful. The literature has used both of these terms interchangeably over the last few decades. In either case, owing to a lack of classic symptoms, there is an invariable delay in diagnosis and treatment of these patients, and often the MI will go undiscovered for months or even years.

Patients who present with symptoms or late complications of a "missed" MI (a term that refers to an individual with chest pain that is inappropriately managed as a noncardiac cause and subsequently found to have sustained an acute MI within the next 24 to 48 hours) represent a different patient cohort [2-4]. The approach to these patients is discussed separately. (See "Overview of the acute management of ST elevation myocardial infarction" and "Overview of the non-acute management of ST elevation myocardial infarction" and "Overview of the acute management of unstable angina and non-ST elevation myocardial infarction" and "Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction".)


There are two principal clinical scenarios in which a previously undiagnosed MI might be suspected. This diagnosis is most commonly associated with the finding of an abnormal electrocardiogram (ECG) with significant abnormalities, usually pathological Q waves, discovered incidentally during a routine health checkup [5,6]. Persistent ST-segment and T wave ECG abnormalities, though less specific for MI than Q waves, can also be signs of prior MI in asymptomatic patients. In this scenario, ECG patterns suggestive of prior MI are often identified by ECG machines with automated interpretation (eg, "cannot exclude anterior MI").


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2017. | This topic last updated: Jul 11, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012; 126:2020.
  2. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342:1163.
  3. McCarthy BD, Beshansky JR, D'Agostino RB, Selker HP. Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med 1993; 22:579.
  4. Lee TH, Rouan GW, Weisberg MC, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987; 60:219.
  5. Savage RM, Wagner GS, Ideker RE, et al. Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: retrospective study of patients with typical anterior and posterior infarcts. Circulation 1977; 55:279.
  6. Horan LG, Flowers NC, Johnson JC. Significance of the diagnostic Q wave of myocardial infarction. Circulation 1971; 43:428.
  7. Ammar KA, Samee S, Makwana R, et al. Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community population. Am J Cardiol 2005; 96:1069.
  8. Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006; 113:2733.
  9. Arenja N, Mueller C, Ehl NF, et al. Prevalence, extent, and independent predictors of silent myocardial infarction. Am J Med 2013; 126:515.
  10. Fordyce CB, Douglas PS. Optimal non-invasive imaging test selection for the diagnosis of ischaemic heart disease. Heart 2016; 102:555.
  11. Kannel WB, Cupples LA, Gagnon DR. Incidence, precursors and prognosis of unrecognized myocardial infarction. Adv Cardiol 1990; 37:202.
  12. Medalie JH, Goldbourt U. Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med 1976; 84:526.
  13. Yano K, MacLean CJ. The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. Arch Intern Med 1989; 149:1528.
  14. Grimm RH Jr, Tillinghast S, Daniels K, et al. Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1987; 75:II6.
  15. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med 1995; 122:96.
  16. Jónsdóttir LS, Sigfusson N, Sigvaldason H, Thorgeirsson G. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Heart J 1998; 19:1011.
  17. Nadelmann J, Frishman WH, Ooi WL, et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. Am J Cardiol 1990; 66:533.
  18. Sheifer SE, Gersh BJ, Yanez ND 3rd, et al. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000; 35:119.
  19. Schelbert EB, Cao JJ, Sigurdsson S, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 2012; 308:890.
  20. Li Y, Dawood FZ, Chen H, et al. Minor isolated Q waves and cardiovascular events in the MESA study. Am J Med 2013; 126:450.e9.
  21. Boland LL, Folsom AR, Sorlie PD, et al. Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study). Am J Cardiol 2002; 90:927.
  22. Cox CJ. Return to normal of the electrocardiogram after myocardial infarction. Lancet 1967; 1:1194.
  23. Asch FM, Shah S, Rattin C, et al. Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: a cardiac magnetic resonance imaging study. Am Heart J 2006; 152:742.
  24. Krittayaphong R, Maneesai A, Chaithiraphan V, et al. Comparison of diagnostic and prognostic value of different electrocardiographic criteria to delayed-enhancement magnetic resonance imaging for healed myocardial infarction. Am J Cardiol 2009; 103:464.
  25. Barbier CE, Bjerner T, Johansson L, et al. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol 2006; 48:765.
  26. Turkbey EB, Nacif MS, Guo M, et al. Prevalence and Correlates of Myocardial Scar in a US Cohort. JAMA 2015; 314:1945.
  27. Weir-McCall JR, Fitzgerald K, Papagiorcopulo CJ, et al. Prevalence of unrecognized myocardial infarction in a low-intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis. Eur Heart J Cardiovasc Imaging 2017; 18:657.
  28. Tresch DD. Management of the older patient with acute myocardial infarction: difference in clinical presentations between older and younger patients. J Am Geriatr Soc 1998; 46:1157.
  29. Arslanian-Engoren C, Patel A, Fang J, et al. Symptoms of men and women presenting with acute coronary syndromes. Am J Cardiol 2006; 98:1177.
  30. Patel H, Rosengren A, Ekman I. Symptoms in acute coronary syndromes: does sex make a difference? Am Heart J 2004; 148:27.
  31. Falcone C, Auguadro C, Sconocchia R, Angoli L. Susceptibility to pain in hypertensive and normotensive patients with coronary artery disease: response to dental pulp stimulation. Hypertension 1997; 30:1279.
  32. Umachandran V, Ranjadayalan K, Ambepityia G, et al. The perception of angina in diabetes: relation to somatic pain threshold and autonomic function. Am Heart J 1991; 121:1649.
  33. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med 2001; 135:801.
  34. Øhrn AM, Nielsen CS, Schirmer H, et al. Pain Tolerance in Persons With Recognized and Unrecognized Myocardial Infarction: A Population-Based, Cross-Sectional Study. J Am Heart Assoc 2016; 5.
  35. Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983; 1:940.
  36. Rosen SD, Paulesu E, Nihoyannopoulos P, et al. Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996; 124:939.
  37. Faerman I, Faccio E, Milei J, et al. Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 1977; 26:1147.
  38. Zhang ZM, Rautaharju PM, Prineas RJ, et al. Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2016; 133:2141.
  39. McAreavey D, Vidal JS, Aspelund T, et al. Midlife Cardiovascular Risk Factors and Late-Life Unrecognized and Recognized Myocardial Infarction Detect by Cardiac Magnetic Resonance: ICELAND-MI, the AGES-Reykjavik Study. J Am Heart Assoc 2016; 5.
  40. de Torbal A, Boersma E, Kors JA, et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 2006; 27:729.
  41. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 1984; 311:1144.
  42. Rosenman RH, Friedman M, Jenkins CD, et al. Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. Am J Cardiol 1967; 19:776.
  43. Rizk DV, Gutierrez O, Levitan EB, et al. Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease. Nephrol Dial Transplant 2012; 27:3482.
  44. Aguilar D, Goldhaber SZ, Gans DJ, et al. Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. Am J Cardiol 2004; 94:337.
  45. Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis 2011; 104:178.
  46. MacDonald MR, Petrie MC, Home PD, et al. Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care 2011; 34:1394.
  47. Burgess DC, Hunt D, Li L, et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J 2010; 31:92.
  48. Davis TME, Fortun P, Mulder J, et al. Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study. Diabetologia 2004; 47:395.
  49. Davis TM, Coleman RL, Holman RR, UKPDS Group. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79. Circulation 2013; 127:980.
  50. Scirica BM. Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus. Circulation 2013; 127:965.
  51. Stacey RB, Leaverton PE, Schocken DD, et al. Prediabetes and the association with unrecognized myocardial infarction in the multi-ethnic study of atherosclerosis. Am Heart J 2015; 170:923.
  52. Barbier CE, Themudo R, Bjerner T, et al. Long-term prognosis of unrecognized myocardial infarction detected with cardiovascular magnetic resonance in an elderly population. J Cardiovasc Magn Reson 2016; 18:43.
  53. Kwong RY, Sattar H, Wu H, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008; 118:1011.
  54. Nordenskjöld AM, Hammar P, Ahlström H, et al. Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance Imaging--Prognostic Implications. PLoS One 2016; 11:e0148803.
  55. Kim HW, Klem I, Shah DJ, et al. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med 2009; 6:e1000057.
  56. Cicala S, de Simone G, Roman MJ, et al. Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation 2007; 116:143.
  57. Sandler LL, Pinnow EE, Lindsay J. The accuracy of electrocardiographic Q waves for the detection of prior myocardial infarction as assessed by a novel standard of reference. Clin Cardiol 2004; 27:97.
  58. Jensen JK, Øvrehus K, Møldrup M, et al. Redefinition of the Q wave -- is there a clinical problem? Am J Cardiol 2006; 97:974.
  59. Gussak I, Wright RS, Bjerregaard P, et al. False-negative and false-positive ECG diagnoses of Q wave myocardial infarction in the presence of right bundle-branch block. Cardiology 2000; 94:165.
  60. Shettigar UR, Pannuri A, Barbier GH, Appunn DO. Significance of anterior Q waves in left anterior fascicular block--a clinical and noninvasive assessment. Clin Cardiol 2002; 25:19.
  61. Bodenheimer MM, Banka VS, Helfant RH. Determination of lead III Q waves significance. Utility of deep inspiration. Arch Intern Med 1977; 137:437.
  62. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129:S49.
  63. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336:1475.
  64. Canto JG, Rogers WJ, Goldberg RJ, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012; 307:813.
  65. Champney KP, Frederick PD, Bueno H, et al. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart 2009; 95:895.
  66. Mehta LS, Beckie TM, DeVon HA, et al. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation 2016; 133:916.
  67. Dagenais GR, Pogue J, Fox K, et al. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 2006; 368:581.
  68. Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011; 364:11.
  69. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341:709.
  70. Tarkin JM, Kaski JC. Pharmacological treatment of chronic stable angina pectoris. Clin Med (Lond) 2013; 13:63.